[
  {
    "ts": null,
    "headline": "Edwards Shoots Higher As It Shrugs Off Tariffs Worries — Until 2026",
    "summary": "Edwards stock shot higher Thursday after the medtech player said tariffs are likely to have little impact in 2025.",
    "url": "https://finnhub.io/api/news?id=461da534318216ecc3c96bb17c5b75f391e60e93f6d1f068a2645b7a203562b7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745525579,
      "headline": "Edwards Shoots Higher As It Shrugs Off Tariffs Worries — Until 2026",
      "id": 134068085,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "Edwards stock shot higher Thursday after the medtech player said tariffs are likely to have little impact in 2025.",
      "url": "https://finnhub.io/api/news?id=461da534318216ecc3c96bb17c5b75f391e60e93f6d1f068a2645b7a203562b7"
    }
  },
  {
    "ts": null,
    "headline": "Edwards Lifesciences (NYSE:EW) Projects 2025 Sales Over US$5.7 Billion With Strong Earnings",
    "summary": "Edwards Lifesciences (NYSE:EW) recently announced its updated guidance, projecting second-quarter 2025 sales between $1.45 billion and $1.53 billion, alongside first-quarter results showing a rise in sales and net income compared to the previous year. This aligns with a broader market trend where the S&P 500 and Nasdaq Composite surged, driven by positive earnings reports and easing concerns over tariffs. The company's 2.2% price move over the last quarter reflects the general optimism but...",
    "url": "https://finnhub.io/api/news?id=b8b552a01f3bc442fde0c14e69c870f4e1111094b7eba37fc8904d2565ff85d6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745519117,
      "headline": "Edwards Lifesciences (NYSE:EW) Projects 2025 Sales Over US$5.7 Billion With Strong Earnings",
      "id": 134068086,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "Edwards Lifesciences (NYSE:EW) recently announced its updated guidance, projecting second-quarter 2025 sales between $1.45 billion and $1.53 billion, alongside first-quarter results showing a rise in sales and net income compared to the previous year. This aligns with a broader market trend where the S&P 500 and Nasdaq Composite surged, driven by positive earnings reports and easing concerns over tariffs. The company's 2.2% price move over the last quarter reflects the general optimism but...",
      "url": "https://finnhub.io/api/news?id=b8b552a01f3bc442fde0c14e69c870f4e1111094b7eba37fc8904d2565ff85d6"
    }
  },
  {
    "ts": null,
    "headline": "Edwards Lifesciences Corp. stock outperforms competitors on strong trading day",
    "summary": "Edwards Lifesciences Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=a9c7b931f63dc1f40c8e6d810ff051e94f79c76e24a231c283091812c2b17666",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745513400,
      "headline": "Edwards Lifesciences Corp. stock outperforms competitors on strong trading day",
      "id": 134080149,
      "image": "",
      "related": "EW",
      "source": "MarketWatch",
      "summary": "Edwards Lifesciences Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=a9c7b931f63dc1f40c8e6d810ff051e94f79c76e24a231c283091812c2b17666"
    }
  },
  {
    "ts": null,
    "headline": "Texas Instruments, Mondelez downgraded: Wall Street's top analyst calls",
    "summary": "Texas Instruments, Mondelez downgraded: Wall Street's top analyst calls",
    "url": "https://finnhub.io/api/news?id=55ac67c9fa0121991f1a6da8a4f9dffd1528231372f6dd343eb52bfd75cb0f83",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745501698,
      "headline": "Texas Instruments, Mondelez downgraded: Wall Street's top analyst calls",
      "id": 134067676,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "Texas Instruments, Mondelez downgraded: Wall Street's top analyst calls",
      "url": "https://finnhub.io/api/news?id=55ac67c9fa0121991f1a6da8a4f9dffd1528231372f6dd343eb52bfd75cb0f83"
    }
  },
  {
    "ts": null,
    "headline": "Q1 2025 Edwards Lifesciences Corp Earnings Call",
    "summary": "Q1 2025 Edwards Lifesciences Corp Earnings Call",
    "url": "https://finnhub.io/api/news?id=85adb9fcfcbd68209560893996491b96e37d3144d42e06c9dd6027dc47cd9d2c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745499057,
      "headline": "Q1 2025 Edwards Lifesciences Corp Earnings Call",
      "id": 134059795,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "Q1 2025 Edwards Lifesciences Corp Earnings Call",
      "url": "https://finnhub.io/api/news?id=85adb9fcfcbd68209560893996491b96e37d3144d42e06c9dd6027dc47cd9d2c"
    }
  },
  {
    "ts": null,
    "headline": "Piper Sandler Upgrades Edwards Lifesciences (EW)",
    "summary": "Piper Sandler Upgrades Edwards Lifesciences (EW)",
    "url": "https://finnhub.io/api/news?id=fc5301c28b2326d4ff9b94e79c326952485062bb4181f7cf448117b6439f9ef6",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745496266,
      "headline": "Piper Sandler Upgrades Edwards Lifesciences (EW)",
      "id": 134059027,
      "image": "",
      "related": "EW",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=fc5301c28b2326d4ff9b94e79c326952485062bb4181f7cf448117b6439f9ef6"
    }
  },
  {
    "ts": null,
    "headline": "Edwards shrugs off tariffs, backs 2025 profit forecast",
    "summary": "The heart valve specialist saw better-than-expected TAVR sales in the first quarter as hospitals addressed capacity constraints that have dogged its core business.",
    "url": "https://finnhub.io/api/news?id=65da49f111630819bfe117396a2d708631397e51bc73ed7d327e3304bb98b17c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745492645,
      "headline": "Edwards shrugs off tariffs, backs 2025 profit forecast",
      "id": 134068088,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "The heart valve specialist saw better-than-expected TAVR sales in the first quarter as hospitals addressed capacity constraints that have dogged its core business.",
      "url": "https://finnhub.io/api/news?id=65da49f111630819bfe117396a2d708631397e51bc73ed7d327e3304bb98b17c"
    }
  },
  {
    "ts": null,
    "headline": "EW Q1 Earnings & Revenues Beat, Stock Climbs, '25 Sales View Raised",
    "summary": "Edwards Lifesciences' first-quarter 2025 performance benefits from its differentiated portfolio of therapies to treat patients with structural heart disease.",
    "url": "https://finnhub.io/api/news?id=f7f358b83afe9b736ed47dbbdd84828f110a5e142c8b8655e2f0ef7f0dacde98",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745491380,
      "headline": "EW Q1 Earnings & Revenues Beat, Stock Climbs, '25 Sales View Raised",
      "id": 134059796,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "Edwards Lifesciences' first-quarter 2025 performance benefits from its differentiated portfolio of therapies to treat patients with structural heart disease.",
      "url": "https://finnhub.io/api/news?id=f7f358b83afe9b736ed47dbbdd84828f110a5e142c8b8655e2f0ef7f0dacde98"
    }
  },
  {
    "ts": null,
    "headline": "Edwards Lifesciences Corp (EW) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ...",
    "summary": "Edwards Lifesciences Corp (EW) reports an 8% increase in total sales, raises full-year guidance, and achieves significant product approvals in Q1 2025.",
    "url": "https://finnhub.io/api/news?id=cabe0fb5e91678c89e34258d4a0e796af0a7b44702f11bfc47ffcfbc20cec6a2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745478495,
      "headline": "Edwards Lifesciences Corp (EW) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ...",
      "id": 134059797,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "Edwards Lifesciences Corp (EW) reports an 8% increase in total sales, raises full-year guidance, and achieves significant product approvals in Q1 2025.",
      "url": "https://finnhub.io/api/news?id=cabe0fb5e91678c89e34258d4a0e796af0a7b44702f11bfc47ffcfbc20cec6a2"
    }
  }
]